Systematic Review and Meta-Analysis of the Diagnostic Accuracy of the World Health Organization International System for Reporting Pancreatic Cytopathology.

IF 1.7 4区 医学 Q3 PATHOLOGY
Acta Cytologica Pub Date : 2025-07-26 DOI:10.1159/000547624
Sana Ahuja, Marzieh Fattahi-Darghlou, Rhea Ahuja, Apoorva Kabra, Sufian Zaheer
{"title":"Systematic Review and Meta-Analysis of the Diagnostic Accuracy of the World Health Organization International System for Reporting Pancreatic Cytopathology.","authors":"Sana Ahuja, Marzieh Fattahi-Darghlou, Rhea Ahuja, Apoorva Kabra, Sufian Zaheer","doi":"10.1159/000547624","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The World Health Organization (WHO), in collaboration with the International Academy of Cytology and the International Agency for Research on Cancer, has introduced a standardized reporting system for pancreatic cytopathology. This system refines diagnostic categories, integrates malignancy risk estimates, and aligns with the WHO Classification of Tumours. It builds on the Papanicolaou Society of Cytopathology framework, improving risk stratification through categories such as pancreatic neoplasm low risk/grade (PaN-Low) and pancreatic neoplasm high risk/grade (PaN-High). This study evaluates the diagnostic accuracy of fine-needle aspiration biopsy (FNAB) for pancreatic lesions using the WHO system.</p><p><strong>Methods: </strong>A systematic literature search was performed in the PubMed and EMBASE databases, using predefined keywords: \"pancreas\", \"FNAB\", and \"diagnostic accuracy\". Meta-analysis was conducted to determine sensitivity and specificity at different diagnostic thresholds: \"PaN-High considered positive,\" \"suspicious for malignancy considered positive,\" and \"malignant considered positive,\" excluding inadequate samples from each study. To assess diagnostic accuracy, summary receiver operating characteristic curves were generated, and the diagnostic odds ratio (DOR) was pooled.</p><p><strong>Results: </strong>Five studies met the inclusion criteria. The risk of malignancy ranged from 3% (negative) to 99% (malignant). Sensitivity and specificity varied across cutoffs: malignant (83%, 100%), suspicious and above (92%, 98%), and PaN-High and above (93%, 96%). DOR values confirmed high diagnostic accuracy.</p><p><strong>Conclusion: </strong>The system effectively stratifies lesions based on malignant potential, with the \"suspicious\" and \"malignant\" categories demonstrating high predictive value. Expanding the diagnostic threshold to include \"PaN-High\" further improves sensitivity without significantly compromising specificity, making it a valuable classification for clinical practice.</p>","PeriodicalId":6959,"journal":{"name":"Acta Cytologica","volume":" ","pages":"1-17"},"PeriodicalIF":1.7000,"publicationDate":"2025-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Cytologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000547624","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The World Health Organization (WHO), in collaboration with the International Academy of Cytology and the International Agency for Research on Cancer, has introduced a standardized reporting system for pancreatic cytopathology. This system refines diagnostic categories, integrates malignancy risk estimates, and aligns with the WHO Classification of Tumours. It builds on the Papanicolaou Society of Cytopathology framework, improving risk stratification through categories such as pancreatic neoplasm low risk/grade (PaN-Low) and pancreatic neoplasm high risk/grade (PaN-High). This study evaluates the diagnostic accuracy of fine-needle aspiration biopsy (FNAB) for pancreatic lesions using the WHO system.

Methods: A systematic literature search was performed in the PubMed and EMBASE databases, using predefined keywords: "pancreas", "FNAB", and "diagnostic accuracy". Meta-analysis was conducted to determine sensitivity and specificity at different diagnostic thresholds: "PaN-High considered positive," "suspicious for malignancy considered positive," and "malignant considered positive," excluding inadequate samples from each study. To assess diagnostic accuracy, summary receiver operating characteristic curves were generated, and the diagnostic odds ratio (DOR) was pooled.

Results: Five studies met the inclusion criteria. The risk of malignancy ranged from 3% (negative) to 99% (malignant). Sensitivity and specificity varied across cutoffs: malignant (83%, 100%), suspicious and above (92%, 98%), and PaN-High and above (93%, 96%). DOR values confirmed high diagnostic accuracy.

Conclusion: The system effectively stratifies lesions based on malignant potential, with the "suspicious" and "malignant" categories demonstrating high predictive value. Expanding the diagnostic threshold to include "PaN-High" further improves sensitivity without significantly compromising specificity, making it a valuable classification for clinical practice.

世界卫生组织国际胰腺细胞病理学报告系统诊断准确性的系统评价和荟萃分析。
世界卫生组织(世卫组织)与国际细胞学学会和国际癌症研究机构合作,推出了胰腺细胞病理学标准化报告系统。该系统改进了诊断类别,整合了恶性肿瘤风险估计,并与世卫组织肿瘤分类保持一致。它建立在Papanicolaou细胞病理学学会框架的基础上,通过胰腺肿瘤-低风险/分级(PaN-Low)和胰腺肿瘤-高风险/分级(PaN-High)等类别来改善风险分层。本研究使用WHO系统评估细针穿刺活检(FNAB)对胰腺病变的诊断准确性。方法以“胰腺”、“FNAB”和“诊断准确性”为关键词,在PubMed和EMBASE数据库中进行系统的文献检索。进行荟萃分析以确定在不同诊断阈值下的敏感性和特异性:“pan -高认为是阳性”,“可疑恶性肿瘤认为是阳性”,“恶性肿瘤认为是阳性”,从每个研究中排除不充分的样本。为了评估诊断的准确性,生成了汇总的受试者工作特征曲线,并汇总了诊断优势比(DOR)。结果5项研究符合纳入标准。恶性肿瘤的风险从3%(阴性)到99%(恶性)不等。敏感性和特异性在截止值上有所不同:恶性(83%,100%),可疑及以上(92%,98%),泛高及以上(93%,96%)。DOR值证实了较高的诊断准确性。结论该系统根据病变的恶性潜能进行了有效的分层,其中“可疑”和“恶性”分类具有较高的预测价值。将诊断阈值扩大到“PaN-High”进一步提高了敏感性,而不会显著影响特异性,使其成为临床实践中有价值的分类。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta Cytologica
Acta Cytologica 生物-病理学
CiteScore
3.70
自引率
11.10%
发文量
46
审稿时长
4-8 weeks
期刊介绍: With articles offering an excellent balance between clinical cytology and cytopathology, ''Acta Cytologica'' fosters the understanding of the pathogenetic mechanisms behind cytomorphology and thus facilitates the translation of frontline research into clinical practice. As the official journal of the International Academy of Cytology and affiliated to over 50 national cytology societies around the world, ''Acta Cytologica'' evaluates new and existing diagnostic applications of scientific advances as well as their clinical correlations. Original papers, review articles, meta-analyses, novel insights from clinical practice, and letters to the editor cover topics from diagnostic cytopathology, gynecologic and non-gynecologic cytopathology to fine needle aspiration, molecular techniques and their diagnostic applications. As the perfect reference for practical use, ''Acta Cytologica'' addresses a multidisciplinary audience practicing clinical cytopathology, cell biology, oncology, interventional radiology, otorhinolaryngology, gastroenterology, urology, pulmonology and preventive medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信